Palisade Bio (PALI) Return on Sales (2011 - 2023)

Palisade Bio (PALI) has 12 years of Return on Sales data on file, last reported at 0.52% in Q4 2023.

• Return on Sales for Q4 2023 came in at 0.52%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was 0.52% (changed N/A YoY), and the FY2023 annual result was 0.52%, changed N/A from the prior year.
• Return on Sales rose to 0.52% in Q4 2023 per PALI's latest filing, from 0.55% in the prior quarter.
• Over five years, Return on Sales peaked at 0.1% in Q1 2023 and troughed at 63.66% in Q3 2022.
• A 4-year average of 14.31% and a median of 7.37% in 2020 frame the typical range for Return on Sales.
• The sharpest annual moves came in 2020 and 2023: Return on Sales sank 524 bps in 2020, then jumped 6311 bps in 2023.
• A 4-year view of Return on Sales shows it stood at 8.5% in 2019, then tumbled by 62 bps to 13.74% in 2020, then plunged by 363 bps to 63.66% in 2022, then surged by 99 bps to 0.52% in 2023.
• Business Quant data shows PALI's Return on Sales at 0.52% in Q4 2023, 0.55% in Q3 2023, and 0.58% in Q2 2023.